EU

Eugit Therapeutics

YC S22

San Francisco, US · Founded 2022 · 2 employees · 1 known investors

eugittx.com ↗

Tissue Targeting Therapies develops therapeutics targeting specific tissues using computational genomics and immunology. The company serves patients through drug development in the biotech/medtech space.

Founders & leadership· Y Combinator alumni (S22)

NB

Nizar BatadainFounder and CEO

YF

Yoshi FukazawainVP of Research / Co-Founder

GC

George ChurchinScientific Advisor / Co-Founder

Investors · 1

Y

Y CombinatorSan Francisco · $500K